Research programme: GlcNAc-TV inhibitors - Inflazyme

Drug Profile

Research programme: GlcNAc-TV inhibitors - Inflazyme

Alternative Names: GlcNAc-TV inhibitors research programme - Inflazyme

Latest Information Update: 30 Jul 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inflazyme Pharmaceuticals
  • Class
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 30 Jul 2004 No development reported - Preclinical for Cancer in Canada (PO)
  • 17 Jun 2003 GLYCODesign has been acquired by Inflazyme Pharmaceuticals
  • 16 Aug 2002 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top